Bharat Biotech's Covaxin Effective Against Delta Plus Covid Variant: Study
NDTV
Delta or the SARS-CoV-2 B.1.617.2 variant, with its high transmissibility, has led to the second wave in India.
Bharat Biotech's Covid-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus, according to a study published in bioRxiv by the Indian Council of Medical and Research (ICMR). The study is a pre-print and has not been peer-reviewed. "Here, we have evaluated the IgG antibody titer and neutralizing potential of sera of COVID-19 naive individuals full doses of BBV152 vaccine, COVID-19 recovered cases with full dose vaccines and breakthrough cases post-immunization BBV152 vaccines against Delta, Delta AY.1 and B.1.617.3.," the study said. The recent emergence of the SARS-CoV-2 Variant B.1.617.2 (Delta) variant with its high transmissibility has led to the second wave in India.More Related News